Chemotherapy for prostate cancer

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.5, Iss.3, 2000-04, pp. : 93-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evolving Strategies of Cytotoxic Chemotherapy for Advanced Prostate Cancer

By Raghavan D. Koczwara B. Javle M.

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 566-574

Elsevier

Access to resources Recommend Favorite

Prostate cancer related haemophagocytic syndrome: Successful treatment with chemotherapy

By Declerck Lydie Adenis Claude Amela Eric Caty Armelle Adenis Antoine Penel Nicolas

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 268-269

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomes

By MacVicar Gary Hussain Maha

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 69-77

Springer Publishing Company

Access to resources Recommend Favorite

Population-based study on use of chemotherapy in men with castration resistant prostate cancer

By Lissbrant Ingela Franck Garmo Hans Widmark Anders Stattin Pär

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1593-1601

Informa Healthcare

Access to resources Recommend Favorite

Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 303-307

Science Publishers

Access to resources Recommend Favorite